DentalEZ will conduct free training seminars for customers who have purchased the Identafi oral screening device or are interested in finding out more about the Identafi. The company has selected 25 locations and dates across the U.S. for the training seminars. Visit the Identafi website to see the complete list. The three-hour seminars are intended for all dental professionals. Attendees who have already purchased the Identafi will gain further insight

Four major U.S. tobacco companies have filed a lawsuit against the U.S. Food and Drug Administration (FDA), challenging the agency’s new graphic cigarette warnings as an unconstitutional way of forcing tobacco manufacturers to disseminate the government’s antismoking message. Lorillard filed the lawsuit August 16 in the U.S. District Court for the District of Columbia along with R.J. Reynolds Tobacco, Commonwealth Brands, and Liggett Group. In June, the FDA announced that

Curis, a drug company developing next-generation targeted small-molecule drug candidates for cancer treatment, announced that the first patient has been treated in a phase I combination trial of its CUDC-101 head and neck cancer drug. The trial is the company’s first CUDC-101 combination study and is designed to test the drug when administered concurrently with radiation and cisplatin in human papillomavirus negative (HPV-) locally advanced head and neck cancer patients.

Medicare’s refusal to cover extensive dental treatment that is often needed to treat patients with diseases such as oral cancer and Sjögren’s syndrome is unreasonable and arbitrary, according to a lawsuit pending in U.S. federal court. The litigation, originally filed in 2008 on behalf of one plaintiff, was recently amended by the Center for Medicare Advocacy (CMA) in the U.S. District Court for the District of Arizona against U.S. Health